Items where Year is 2024

Group by: Creators | Item Type | No Grouping
Jump to: C | G | K | M | N | R
Number of items: 7.

C

Chandrasekaran, Padmapriyadarsini and Szumowski, John D. and Akbar, Nabila and Shanmugasundaram, Prema and Jain, Anilkumar and Bathragiri, Marasamy and Pattnaik, Manoranjan and Turuk, Jyotirmayee and Karunaianantham, Ramesh and Balakrishnan, Senthilkumar and Pati, Sanghamitra and Hemanth Kumar, AK and Rathore, Manoj Kumar and Raja, Jegadeesh and Raghu Naidu, K and Horn, John and Whitworth, Laura and Sewell, Roger and Ramakrishnan, Lalita and Swaminathan, Soumya and Edelstein, Paul H (2024) A Dose-Finding Study to Guide Use of Verapamil as an Adjunctive Therapy in Tuberculosis. A Dose-Finding Study to Guide Use of Verapamil as an Adjunctive Therapy in Tuberculosis, 115 (2). pp. 324-332.

G

Giridharan, Prathiksha and Murugesan, Havenesh and Selvaraju, Sriram and Frederick, Asha and Selvavinayagam, T S and Nagarajan, Karikalan and Thiruvengadam, Kannan and Krishnan, Rajendran and Paul Kumaran, Paramasivam and Marimuthu, Makeshkumar and Chandrasekeran, Padmapriyadharshini (2024) Operational Challenges in Conducting a Subnational TB Prevalence Survey in India: Lessons Learned for Resource-Limited, High-Burden Settings. Operational Challenges in Conducting a Subnational TB Prevalence Survey in India: Lessons Learned for Resource-Limited, High-Burden Settings, 12 (1). pp. 1-6.

K

Kulkarni, P S and Chandrasekaran, Padmapriyadarsini and Vekemans, J and Bavdekar, A and Gupta, M and Kulkarni, P and Garg, B S and Nithya, J and Gogtay, Gogtay and Tambe, M and Lalwani, S and Singh, Kiranjit and Munshi, R and Meshram, S and Selvavinayagam, T S and Pandey, Krishna and Bhimarasetty, D M and Ramakrishnan, S R and Bhamare, C and Dharmadhikari, A and Budhawant, C and Bonhomme, Cyrille J and Thakar, M and Kurle, S N and Gautam, M and Gupta, Nivedita and Panda, Samiran and Bhargava, Balram and Poonawalla, Cyrus S and Shaligram, U and Kapse, D and Gunale, B (2024) Seropersistence of SII-ChAdOx1 nCoV-19 (COVID-19 vaccine): 6-month follow-up of a randomized,controlled, observer-blind, phase 2/3 immuno-bridging study in Indian adults. Seropersistence of SII-ChAdOx1 nCoV-19 (COVID-19 vaccine): 6-month follow-up of a randomized,controlled, observer-blind, phase 2/3 immuno-bridging study in Indian adults, 20 (1).

Kumar, S R and Hissar, S.S, S S and Ramesh, P M and Shanmugam, M and Kalaiselvan, V. and Prakash, J and Padmapriyadarsini, C (2024) Ethambutol-induced optic neuropathy: should we mandate ophthalmic examination in TB treatment? Ethambutol-induced optic neuropathy: should we mandate ophthalmic examination in TB treatment?, 28 (1). pp. 51-53.

M

Malaisamy, Muniyandi and Nagarajan, Karikalan and Mathiyazhagan, K and Giridharan, Prathiksha and Thiruvengadam, Kannan and Krishnan, Rajendran (2024) The Predicted Potential Impact of COVID-19 Pandemic on Tuberculosis Epidemic in Tamil Nadu, South India. The Predicted Potential Impact of COVID-19 Pandemic on Tuberculosis Epidemic in Tamil Nadu, South India, 9 (12). pp. 1-14.

N

Naveen Kumar, R and Selvaraj, Ashok and Sembulingam, Tamilzhalagan and Panpatil, Virendra and Venkatesh, Kaliaperumal and Gowthami, SDG and Putchaa, Udaykumar and Ranganathan, Uma Devi and Rajkumar, Hemalatha and Ghosh, Sudip and Bethunaickan, Ramalingam (2024) Whole genome sequencing of bacteriophage NINP13076 isolated against Salmonella enteritidis. Whole genome sequencing of bacteriophage NINP13076 isolated against Salmonella enteritidis, 30 (100223). pp. 1-8. ISSN 2405-9854

R

Ramesh Kumar, S and Narendran, G and Padmapriyadarsini, Chandrasekaran (2024) Role for Linezolid in drug sensitive tuberculosis. Role for Linezolid in drug sensitive tuberculosis, 17 (1). pp. 172-174.

This list was generated on Thu May 2 04:58:23 2024 UTC.